Abstract
Interim Results of the Phase I/II Study of the Ponatinib, Venetoclax and Dexamethasone for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have